Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2400136 | 0.78 | QPCT (0.52) | QPCT | |
| SCHEMBL2394839 | 0.77 | QPCT (0.51) | QPCT | |
| SCHEMBL1706589 | 0.77 | QPCT (0.84) | QPCT | |
| SCHEMBL2397541 | 0.76 | QPCTL (0.42) | QPCTQPCTL | |
| SCHEMBL2397650 | 0.75 | QPCT (0.45) | QPCTQPCTL | |
| SCHEMBL1706078 | 0.73 | QPCT (0.83) | QPCT | |
| SCHEMBL13373351 | 0.71 | ALDH1A1 (0.46) | QPCTQPCTL | |
| SCHEMBL2395925 | 0.70 | QPCT (0.57) | QPCTQPCTL | |
| SCHEMBL1706431 | 0.69 | QPCT (0.50) | QPCT | |
| SCHEMBL2398225 | 0.69 | QPCT (0.46) | QPCTQPCTL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9181233-B2 | Inhibitors of glutaminyl cyclase | PROBIODRUG AG (DE) | 2015-11-10 | — | — | US | disclosed |
| US-20110224259-A1 | NOVEL INHIBITORS | PROBIODRUG AG (DE) | 2011-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224259-A1 | NOVEL INHIBITORS | QPCT, GLUL, GLS | QPCT 1/4885QPCTL 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.